US
New FDA head aims for aggressive enforcement
August 11, 2009Research and Development, Sales and Marketing FDA, US, drug safety
The new head of US regulator the FDA has set out a vision to support public health, through tighter laws …
Centocor launches online arthritis talk show
August 4, 2009Medical Communications, Sales and Marketing Centacor, RA, US, digi
An online talk show for rheumatoid arthritis patients has been launched in the US with the aim of raising awareness …
Avastin gets US approval in kidney cancer
August 4, 2009Research and Development, Sales and Marketing Roche, US, avastin
Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …
The Trillion Dollar Project: US healthcare reform begins
July 17, 2009Sales and Marketing Obama, US, healthcare, reform
The battle to determine how the US healthcare system will be reformed is heating up, with dozens of interest groups …
Effient approved in US
July 17, 2009Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly
Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …
US approval boosts Plavix competitor
July 14, 2009Research and Development, Sales and Marketing Effient, FDA, US, lilly
US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …
Writing on the wall for ‘pay to delay’ generics deals
July 9, 2009Research and Development, Sales and Marketing FDA, US, generics
Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …
Genzyme’s woes are a boost for Shire and Protalix
July 9, 2009Research and Development, Sales and Marketing FDA, Genzyme, US
The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …
Depression warnings for Chantix and Zyban
July 7, 2009Research and Development, Sales and Marketing Chantix, FDA, US, drug safety
Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …
Dendreon sets aside $50m for Provenge facility
June 24, 2009Manufacturing and Production Dendreon, US
US biotechnology company Dendreon revealed its confidence in lead drug Provenge for prostate cancer with the announcement it will invest …
Pharma agrees cost-saving deal with US government
June 24, 2009Sales and Marketing Medicare, US, US healthcare, healthcare
Drug makers have agreed with the US government to spend $80 billion over the next ten years in a bid …
Battle ahead for US industry over biologics patents
June 12, 2009Research and Development, Sales and Marketing PhRMA, US, generics, industry, reform
Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …
The pharmaceutical industry faces unprecedented barriers to evolution
June 10, 2009Research and Development US, healthcare
Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused …
FDA to improve transparency
June 3, 2009Research and Development FDA, US
The US medicines regulator is to boost the transparency around its decision-making, in connection with President Obama's aim to make …
Latest content
FibroFind appoints Lee Borthwick as CEO
